Valuation : Abbott Laboratories

Market Cap 188B 163B 153B 139B 262B 17,889B 263B 1,808B 704B 9,100B 708B 692B 30,173B P/E 2026 *
31.2x
P/E 2027 * 24.1x
Enterprise Value 212B 183B 172B 157B 295B 20,161B 297B 2,038B 793B 10,255B 798B 780B 34,005B EV / Sales 2026 *
4.22x
EV / Sales 2027 * 3.83x
Free-Float
86.16%
Yield 2026 *
2.36%
Yield 2027 * 2.52%
1 day-1.30%
1 week-6.20%
Current month-1.30%
1 month+3.06%
3 months+24.09%
6 months-6.38%
Current year-13.06%
1 week 108.68
Extreme 108.68
113.91
1 month 104.2
Extreme 104.2
117.34
Current year 81.97
Extreme 81.97
129.46
1 year 81.97
Extreme 81.97
137.49
3 years 81.97
Extreme 81.97
141.23
5 years 81.97
Extreme 81.97
142.6
10 years 37.38
Extreme 37.38
142.6
Manager TitleAgeSince
Chief Executive Officer 52 30/03/2020
Director of Finance/CFO 53 31/08/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 08/12/2011
Director/Board Member 67 08/12/2011
Director/Board Member 71 15/02/2017
Date Insider Type Main position Quantity % Market Cap. Importance
25/08/26 Exercice

Chief Executive Officer

1,196,496 0.0691%
12/08/26 Other

EXECUTIVE VICE PRESIDENT

-12 0.0000% -
30/06/26 Free

Director

416 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-1.30%-6.20%-17.89%+5.91% 188B
+1.53%+0.99%-0.83%+12.07% 118B
+2.28%+0.89%+13.50%+89.17% 63.16B
-1.69%-2.04%+26.38%+48.75% 52.01B
-0.53%-1.40%-3.04%-32.80% 50.97B
-1.01%+1.10%+19.64%-11.54% 34.02B
+0.23%-1.49% - - 30.8B
-0.72%-2.82%+37.13%-16.93% 23.83B
-2.61%-3.71%-7.09%+14.02% 23.45B
-1.29%-2.87%-6.29%-0.53% 22.39B
Average -0.52%-1.78%+6.84%+12.01% 60.69B
Weighted average by Cap. -0.29%-2.62%-0.27%+14.84%

Financials

2026 *2027 *
Net sales 50.3B 43.39B 40.82B 37.18B 69.92B 4,774B 70.3B 483B 188B 2,428B 189B 185B 8,052B 54.65B 47.14B 44.34B 40.39B 75.96B 5,186B 76.37B 524B 204B 2,638B 205B 201B 8,748B
Net income 6.23B 5.38B 5.06B 4.61B 8.66B 591B 8.71B 59.78B 23.27B 301B 23.4B 22.89B 998B 7.92B 6.84B 6.43B 5.86B 11.02B 752B 11.08B 76.01B 29.59B 383B 29.75B 29.11B 1,269B
Net Debt 23.94B 20.65B 19.42B 17.7B 33.28B 2,272B 33.46B 230B 89.38B 1,156B 89.88B 87.93B 3,832B 20.96B 18.08B 17B 15.49B 29.13B 1,989B 29.29B 201B 78.25B 1,012B 78.68B 76.98B 3,355B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change Volume
01/09/26 US$108.93 -1.30% 7,229,416
31/08/26 US$110.36 -1.88% 10,691,544
28/08/26 US$112.47 +0.79% 7,545,562
27/08/26 US$111.59 -2.20% 8,355,172
26/08/26 US$114.10 -1.75% 6,959,229
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
108.93USD
Average target price
120.20USD
Spread / Average Target
+10.35%

Quarterly revenue - Rate of surprise